Skip to content

Functional Brain Imaging of Pain Phenotype and Genotype

Brain Imaging of Pain Phenotype and Genotype With Novel Scanning Techniques

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01777087
Enrollment
15
Registered
2013-01-28
Start date
2013-01-31
Completion date
2016-03-31
Last updated
2018-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Keywords

Pain, Functional Magnetic Resonance Imaging

Brief summary

This study has two purposes: first, to locate and identify the brain activation (the areas of the brain) which respond to pain; and second, to look at how brain activation is influenced by a person's genetics (the traits they inherited from their parents). A Magnetic Resonance Imaging (MRI) scanner will be used to gather pictures of the brain (similar to an x-ray, but based on different scientific principles) that will be used to determine which areas are active. The hypothesis is that the variation in brain activity between people can be partially explained by genetic differences. This study consists of an two pain tasks applied during a one time visit to the MRI suite. There are no followup visits.

Interventions

OTHERgauze soaked with capsaicin

This is a basic science study determining the brain activation that results from painful stimulation. All subjects will have the same painful stimulations and brain images collected.

Sponsors

University of Pittsburgh
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 18 to 50 * Right-handed * Male or female * Healthy individuals not taking any medication.

Exclusion criteria

* Pregnancy * Diagnosed with any treated or untreated medical or neurological conditions * Using any prescription drugs, including antidepressants, pain medications, sedative medications, blood pressure medications, seizure medications, or antipsychotics. Oral contraceptives are permitted * Using any over-the-counter medications including aspirin, Tylenol, or herbal supplements * Using any illicit substances * Contraindications to magnetic resonance imaging.

Design outcomes

Primary

MeasureTime frameDescription
Areas of brain activity from a transcutaneous painful stimulationAt the conclusion of the 1 hour scanning session; Visit oneA nerve stimulator will be turned on at the level that causes you to report 7/10 pain for 30 seconds, followed by a 30 second period of rest. This will be repeated four times. The areas of brain activity are determined at the end of the 1 hour scanning session by analyzing the brain images. There are no additional followup or long term outcomes.
Areas of brain activity from a 45 minutes Capsaicin cream applicationAt the conclusion of the 1 hour scanning session; Visit 1The painful stimulation will now be caused by placing a piece of gauze soaked with capsaicin, the active ingredients in chili peppers, on the subject's right arm. The areas of brain activity are determined at the end of the 1 hour scanning session by analyzing the brain images. There are no additional followup or long term outcomes.

Secondary

MeasureTime frameDescription
Pain phenotypingAfter the 45 minute Capsaicin cream application; Visit 1Subjects will report their pain at least every 3 minutes during the cream application. The subject's pain phenotype will be determined from this response.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026